Accessibility Menu
Jbs Stock Quote

Jbs (NYSE: JBS)

$14.35
(-4.1%)
-0.62
Price as of December 5, 2025, 4:00 p.m. ET

KEY DATA POINTS

Current Price
$14.35
Daily Change
(-4.1%) $0.62
Day's Range
$14.15 - $14.78
Previous Close
$14.35
Open
$14.78
Beta
0.52
Volume
7,854,918
Average Volume
6,062,835
Market Cap
14.8B
Market Cap / Employee
$14.35M
52wk Range
$9.73 - $17.80
Revenue
-
Gross Margin
0.13%
Dividend Yield
N/A
EPS
$1.52
CAPs Rating
-
Industry
Food Products

The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More

Jbs Return vs. S&P

1 Year5 Year5 Year AnnualizedSince IPO
JBS+18.63%+135.24%+18.64%+3%
S&P+13.09%+85.73%+13.17%+15%
Advertisement

Jbs Company Info

JBS SA engages in the processing of beef, pork, lamb, chicken, and also produces value added and convenience food products. It operates through the following business segments: JBS Brazil, Seara, USA Beef, USA Pork, and Pilgrim's Pride. The JBS Brazil segment includes all the operating activities from Company and its subsidiaries, mainly represented by slaughter facilities, cold storage and meat processing, fat, and feed and production of beef by-products such as leather, collagen and others products produced in Brazil. The Seara segment includes all the operating activities of Seara and its subsidiaries, mainly represented by chicken and pork processing, production and commercialization of food products. The USA Beef segment includes JBS USA's operations, including Australia and Canada as well, related to beef processing: slaughter, cold storage, production and others beef byproducts, besides cattle fattening services. The USA Pork segment includes JBS USA's pork operations, including Plumrose and Australia as well, related to slaughter, cold storage, production and commercialization of food products. The Pilgrim's Pride includes poultry, pork, and beef production. The company was founded by José Batista Sobrinho in 1953 and is headquartered in Vila Jaguara, Brazil.

News & Analysis

No results found

No news articles found for Jbs.

Financial Health

General

Q3 2025YOY Change
Revenue$22.59B0.0%
Gross Profit$2.91B0.0%
Gross Margin12.87%0.0%
Market Cap$15.75B28.0%
Market Cap / Employee$0.06M0.0%
Employees280K3.7%
Net Income$644.00M274.9%
EBITDA$1.79B35373807.7%

Currently no data to display

Revenue Growth Rate

Currently no data to display.

Earnings Per Share Growth Rate

Currently no data to display.

Assets

Q3 2025YOY Change
Net Cash$3.55B32799969.5%
Accounts Receivable$3.84B0.0%
Inventory8.4K0.0%

Liabilities

Q3 2025YOY Change
Long Term Debt$21.18B0.0%
Short Term Debt$1.35B0.0%

Ratios

Q3 2025YOY Change
Return On Assets5.75%0.0%
Return On Invested Capital109.49%101.8%

Cash Flow

Q3 2025YOY Change
Free Cash Flow$464.46M10367295.8%
Operating Free Cash Flow$1.04B23197107.7%

Valuation

MetricQ4 2024Q1 2025Q2 2025Q3 2025YoY Change
Price to Earnings13.1414.6211.129.82-41.46%
Price to Book1.472.103.951.8726.46%
Price to Sales0.730.35-
Price to Tangible Book Value15.831333.143.9523.4134.13%
Price to Free Cash Flow TTM30.5725.48-
Enterprise Value to EBITDA-234960.08-386008.1920.7019.40-100.00%
Free Cash Flow Yield3.3%3.9%-
Return on Equity21.4%22.5%17.7%24.2%-
Total Debt$0.00M$0.00M$21.26B$22.54B-

No results found

No podcast episodes available.

No results found

No transcripts available.

Advertisement

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.